Physician profile
John S Oldham
NPI 1699817429
$514,563.00
in general payments reported to CMS, 2019-2025
25 companies · $100K in 2025
The $100K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $11K · 2021: $21K · 2022: $87K · 2023: $119K · 2024: $154K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $324K · Consulting Fee: $40K · Food and Beverage: $4,881 · Travel and Lodging: $3,060 · Education: $969 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $324,000.00 |
| Consulting Fee | $40,000.00 |
| Food and Beverage | $4,880.95 |
| Travel and Lodging | $3,060.28 |
| Education | $969.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $364,890.72 | 2023-2025 | Titan Sgs, Titan Sgs Standard Gastric Stapler, Titan Sgs Bailout Chuck |
| Standard Bariatrics, INC. | $127,104.79 | 2019-2022 | |
| Intuitive Surgical, INC. | $10,865.20 | 2019-2025 | Da Vinci Surgical System |
| Conmed Corporation | $3,065.81 | 2023-2025 | System 2450, Airseal |
| Baxter Healthcare | $2,328.01 | 2019-2024 | Tisseel |
| Ethicon US, LLC | $2,272.90 | 2019-2023 | Linx Reflux Management System, Echelon Flex |
| Medical Device Business Services, INC. | $1,518.46 | 2019-2020 | |
| Covidien LP | $547.10 | 2019 | |
| Medtronic, INC. | $463.76 | 2021-2025 | Corevalve Evolut R, Signia |
| Teleflex Medical Incorporated | $281.88 | 2023 | Titan Sgs Standard Gastric Stapler |
| Novo Nordisk INC | $279.92 | 2019-2025 | Wegovy |
| Endo Pharmaceuticals INC. | $204.71 | 2019-2022 | |
| Lilly USA, LLC | $141.66 | 2023-2025 | Zepbound |
| Echosens North America, INC. | $126.83 | 2024 | Fibroscan |
| Avanos Medical | $78.06 | 2023-2024 | On-Q* Pump and Accessories |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $77.18 | 2025 | |
| Karl Storz Endoscopy-America | $72.89 | 2020-2022 | |
| Gt Metabolic Solutions INC | $68.34 | 2025 | |
| Phathom Pharmaceuticals, INC. | $47.45 | 2024 | Voquezna |
| Redhill Biopharma INC. | $46.93 | 2023 | Movantik, Talicia, Aemcolo |
| Takeda Pharmaceuticals U.S.A., INC. | $18.37 | 2022 | |
| Cook Medical LLC | $17.63 | 2019 | |
| Vivus LLC | $16.84 | 2019 | |
| Monaghan Medical Corporation | $15.57 | 2019 | |
| Merck Sharp & Dohme LLC | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Oldham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.